# EyePoint Pharmaceuticals, Inc.

Type: Company (EYPT)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/eyepoint-pharmaceuticals-inc
Canonical HTML page: https://gethealthbrief.com/entity/eyepoint-pharmaceuticals-inc

## Recent coverage (1 stories)

### Essex Woodlands Trims EyePoint Pharmaceuticals Stake Amid Pipeline Focus
2026-02-28 00:58:31 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Essex Woodlands Management Inc. reduced its position in EyePoint Pharmaceuticals by 7.3% in the third quarter, while maintaining a significant $15.45 million stake. The move reflects a strategic rebalancing as EyePoint advances its late-stage ophthalmic pipeline, particularly its DURAVYU™ platform.
Full story: https://gethealthbrief.com/story/essex-woodlands-eyepoint-pharmaceuticals-stake-reduction

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.